 SOUTH SAN FRANCISCO, Calif., Nov. 02, 2022 GLOBE NEWSWIRE -- CytomX Therapeutics, Inc. Nasdaq: CTMX, a leader in the field of conditionally activated oncology therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in the following investor conferences in November. 